
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 41982
[patent_doc_number] => 07780948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Post biopsy cavity treatment implants and methods'
[patent_app_type] => utility
[patent_app_number] => 12/256619
[patent_app_country] => US
[patent_app_date] => 2008-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 60
[patent_no_of_words] => 16032
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/780/07780948.pdf
[firstpage_image] =>[orig_patent_app_number] => 12256619
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/256619 | Post biopsy cavity treatment implants and methods | Oct 22, 2008 | Issued |
Array
(
[id] => 5265583
[patent_doc_number] => 20090118268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/249386
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29000
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12249386
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/249386 | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS | Oct 9, 2008 | Abandoned |
Array
(
[id] => 5361713
[patent_doc_number] => 20090036507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'BIS (CYANOPHENYL) METHYL-TRIAZOLE FOR USE IN PREVENTION OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/246857
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6635
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036507.pdf
[firstpage_image] =>[orig_patent_app_number] => 12246857
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/246857 | BIS (CYANOPHENYL) METHYL-TRIAZOLE FOR USE IN PREVENTION OF BREAST CANCER | Oct 6, 2008 | Abandoned |
Array
(
[id] => 5580619
[patent_doc_number] => 20090175965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'USE OF UNSAPONIFIABLE COMPONENTS OF VEGETABLE OILS FOR PREPARING A COSMETIC AND RELATED TREATMENTS'
[patent_app_type] => utility
[patent_app_number] => 12/244728
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7983
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175965.pdf
[firstpage_image] =>[orig_patent_app_number] => 12244728
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/244728 | Use of unsaponifiable components of vegetable oils for preparing a cosmetic and related treatments | Oct 1, 2008 | Issued |
Array
(
[id] => 6276491
[patent_doc_number] => 20100256237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'POTENTIATING THE EFFECT OF COMPOUND COMPRISING NITRIC OXIDE'
[patent_app_type] => utility
[patent_app_number] => 12/675822
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3716
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256237.pdf
[firstpage_image] =>[orig_patent_app_number] => 12675822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/675822 | Potentiating the effect of compound comprising nitric oxide | Oct 1, 2008 | Issued |
Array
(
[id] => 8006085
[patent_doc_number] => 08084443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Biological specimen collection and transport system and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/243949
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 15921
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084443.pdf
[firstpage_image] =>[orig_patent_app_number] => 12243949
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/243949 | Biological specimen collection and transport system and methods of use | Sep 30, 2008 | Issued |
Array
(
[id] => 5515460
[patent_doc_number] => 20090215767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'ISOFLAVONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/241671
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4046
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215767.pdf
[firstpage_image] =>[orig_patent_app_number] => 12241671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/241671 | Isoflavone derivatives and pharmaceutical compositions comprising the same | Sep 29, 2008 | Issued |
Array
(
[id] => 5501766
[patent_doc_number] => 20090162454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Compositions and Methods for Effecting NAD+ Levels Using A Nicotinamide Phosphoribosyl Tranferase Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/237755
[patent_app_country] => US
[patent_app_date] => 2008-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 31571
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162454.pdf
[firstpage_image] =>[orig_patent_app_number] => 12237755
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/237755 | Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl tranferase inhibitor | Sep 24, 2008 | Issued |
Array
(
[id] => 8214232
[patent_doc_number] => 08193147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Use of copolymer 1 for treatment of muscular dystrophy'
[patent_app_type] => utility
[patent_app_number] => 12/679866
[patent_app_country] => US
[patent_app_date] => 2008-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7554
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193147.pdf
[firstpage_image] =>[orig_patent_app_number] => 12679866
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/679866 | Use of copolymer 1 for treatment of muscular dystrophy | Sep 23, 2008 | Issued |
Array
(
[id] => 7966579
[patent_doc_number] => 07939560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Fluorescent particles comprising nanoscale ZnO layer and exhibiting cell-specific toxicity'
[patent_app_type] => utility
[patent_app_number] => 12/235575
[patent_app_country] => US
[patent_app_date] => 2008-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 7802
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939560.pdf
[firstpage_image] =>[orig_patent_app_number] => 12235575
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/235575 | Fluorescent particles comprising nanoscale ZnO layer and exhibiting cell-specific toxicity | Sep 21, 2008 | Issued |
Array
(
[id] => 6516927
[patent_doc_number] => 20100261682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Method and Means for the Treatment of Cachexia'
[patent_app_type] => utility
[patent_app_number] => 12/676173
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15200
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261682.pdf
[firstpage_image] =>[orig_patent_app_number] => 12676173
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676173 | Method and Means for the Treatment of Cachexia | Sep 16, 2008 | Abandoned |
Array
(
[id] => 7518928
[patent_doc_number] => 07973029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases'
[patent_app_type] => utility
[patent_app_number] => 12/210965
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27439
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/973/07973029.pdf
[firstpage_image] =>[orig_patent_app_number] => 12210965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/210965 | Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases | Sep 14, 2008 | Issued |
Array
(
[id] => 82750
[patent_doc_number] => 07740896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/230915
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 19296
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/740/07740896.pdf
[firstpage_image] =>[orig_patent_app_number] => 12230915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/230915 | Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof | Sep 7, 2008 | Issued |
Array
(
[id] => 71982
[patent_doc_number] => 07754748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'Method for treating obesity'
[patent_app_type] => utility
[patent_app_number] => 12/205769
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5475
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754748.pdf
[firstpage_image] =>[orig_patent_app_number] => 12205769
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/205769 | Method for treating obesity | Sep 4, 2008 | Issued |
Array
(
[id] => 5453233
[patent_doc_number] => 20090069270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Methods for Diluting Water-Stabilized Antimicrobial Organosilane Compositions'
[patent_app_type] => utility
[patent_app_number] => 12/203213
[patent_app_country] => US
[patent_app_date] => 2008-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16447
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069270.pdf
[firstpage_image] =>[orig_patent_app_number] => 12203213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/203213 | Methods for diluting water-stabilized antimicrobial organosilane compositions | Sep 2, 2008 | Issued |
Array
(
[id] => 6510303
[patent_doc_number] => 20100210733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Composition for Prevention or Treatment of Bone Metabolism Disorder Comprising D-Pinitol as an Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/676481
[patent_app_country] => US
[patent_app_date] => 2008-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6144
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210733.pdf
[firstpage_image] =>[orig_patent_app_number] => 12676481
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676481 | Composition for prevention or treatment of bone metabolism disorder comprising D-pinitol as an active ingredient | Sep 2, 2008 | Issued |
Array
(
[id] => 4534396
[patent_doc_number] => 07888337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => 'Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity'
[patent_app_type] => utility
[patent_app_number] => 12/201955
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 33
[patent_no_of_words] => 26581
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/888/07888337.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201955
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201955 | Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity | Aug 28, 2008 | Issued |
Array
(
[id] => 42840
[patent_doc_number] => 07781423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Compounds to promote regeneration of bone marrow'
[patent_app_type] => utility
[patent_app_number] => 12/201914
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8213
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781423.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201914 | Compounds to promote regeneration of bone marrow | Aug 28, 2008 | Issued |
Array
(
[id] => 5522053
[patent_doc_number] => 20090030034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'USE OF FGF INHIBITING SUBSTITUTED 1,2,3 INDOLIZINE DERIVATIVES IN THE PREPARATION OF MEDICAMENTS WHICH CAN BE USED TO TREAT DISEASES LINKED TO PATHOLOGICAL CHOROIDAL ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/201075
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3764
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030034.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201075
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201075 | Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis | Aug 28, 2008 | Issued |
Array
(
[id] => 4574602
[patent_doc_number] => 07825084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Methods and compositions for increasing the anaerobic working capacity in tissues'
[patent_app_type] => utility
[patent_app_number] => 12/231240
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 11770
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/825/07825084.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231240
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231240 | Methods and compositions for increasing the anaerobic working capacity in tissues | Aug 28, 2008 | Issued |